CDEK
← All drugs Report issue

lm-302

mAbexperimental

Clinical trial activity

9 trials · 28 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
9
Phase 3
1
Phase 4
0

Earliest trial started Dec 15, 2021 (NCT05001516)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07108504Phase 2Aug 10, 2025Fudan University
NCT06519591Phase 2Jul 31, 2024Jiao Tong University
NCT06587425Phase 2Jul 31, 2024Fudan University
NCT06351020Phase 3Jun 24, 2024Chinese Academy of Medical Sciences, Huazhong University of Science and Technology, LaNova Medicines Limited
NCT05994001Phase 1/Phase 2 (Phase 2)Aug 1, 2023Fudan University
NCT05934331Phase 2Jul 27, 2023Chinese Academy of Medical Sciences, Chongqing Medical University, Fudan University, Huazhong University of Science and Technology, LaNova Medicines Limited, Nanyang Central Hospital, Shanghai Xuhui District Central Hospital, Shenzhen University, The First People's Hospital of Changzhou, Tianjin Medical University, Wannan Medical College, Wuhan University, Xiamen University, Zhejiang University, Zibo City First Hospital
NCT05188664Phase 1/Phase 2 (Phase 2)May 10, 2022Chris O'Brien Lifehouse, LaNova Medicines Limited, Macquarie University, Monash University, Peninsula & South Eastern Haematology & Oncology Group
NCT05161390Phase 1/Phase 2 (Phase 2)Dec 30, 2021Fudan University, Harbin Medical University, Huazhong University of Science and Technology, Jiao Tong University, LaNova Medicines Limited, Nanchang University, Shandong Provincal Cancer Hospital
NCT05001516Phase 1/Phase 2 (Phase 2)Dec 15, 2021City of Hope National Medical Center, Horizon Oncology Research, Inc., LaNova Medicines Limited, Mercy Clinic Oncology and Hematology, University of Texas at Houston, University of Toledo
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (28)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Fudan UniversityAcademic/Hospital5312021
LaNova Medicines LimitedFor profit5522021
Huazhong University of Science and TechnologyAcademic/Hospital3022021
Chinese Academy of Medical SciencesAcademic/Hospital2022023
Jiao Tong UniversityAcademic/Hospital2112021
Chongqing Medical UniversityAcademic/Hospital1012023
Chris O'Brien LifehouseAcademic/Hospital1012022
City of Hope National Medical CenterAcademic/Hospital1012021
Harbin Medical UniversityAcademic/Hospital1012021
Horizon Oncology Research, Inc.For profit1012021
Macquarie UniversityAcademic/Hospital1012022
Mercy Clinic Oncology and HematologyAcademic/Hospital1012021
Monash UniversityAcademic/Hospital1012022
Nanchang UniversityAcademic/Hospital1012021
Nanyang Central HospitalAcademic/Hospital1012023
Peninsula & South Eastern Haematology & Oncology GroupAcademic/Hospital1012022
Shandong Provincal Cancer HospitalAcademic/Hospital1012021
Shanghai Xuhui District Central HospitalAcademic/Hospital1012023
Shenzhen UniversityAcademic/Hospital1012023
The First People's Hospital of ChangzhouAcademic/Hospital1012023
28 organizations
Page 1 / 2